What's Happening?
Accel and Prosus have announced the selection of six startups for their first joint Atoms cohort in India, focusing on science-led innovations in healthcare, climate, space, and longevity. The cohort was chosen from over 2,000 applications and aims to support
startups tackling complex, undefined markets. The program emphasizes patient, high-variance outcomes and provides funding between $500,000 and $2 million, with a portion deferred to reduce early-stage dilution.
Why It's Important?
This initiative represents a significant investment in deep tech innovation, which is crucial for addressing global challenges such as climate change and healthcare. By supporting startups in these areas, Accel and Prosus are fostering technological advancements that could lead to significant breakthroughs. The program's focus on long-term outcomes rather than immediate financial returns could influence venture capital strategies and encourage more investment in high-impact technologies.
